首页> 外文期刊>Cancer biology & therapy >Suppression of CX43 expression by miR-20a in the progression of human prostate cancer
【24h】

Suppression of CX43 expression by miR-20a in the progression of human prostate cancer

机译:miR-20a在人类前列腺癌进展中抑制CX43表达

获取原文
获取原文并翻译 | 示例
       

摘要

The aberrant expression of microRNAs (miRNAs) has been found in various types of cancer. The present study found miR-20a to be significantly upregulated in prostate cancer compared with normal prostate tissues. The proliferation and colony formation assays revealed that the downregulation of miR-20a by miR-20a inhibitor suppresses the proliferation of MDA-PCa-2b cells in vitro and also inhibits tumor growth in vivo. Furthermore, a gap junction protein, α1 (CX43), was identified as a direct target gene of miR-20a. The upregulation of CX43 was detected in MDA-PCa-2b cells after treatment with miR-20a inhibitor both in vitro and in vivo. In conclusion, the findings show that miR-20a significantly contributes to the progression of prostate cancer by targeting CX43.
机译:在各种类型的癌症中都发现了microRNA(miRNA)的异常表达。本研究发现与正常前列腺组织相比,miR-20a在前列腺癌中显着上调。增殖和集落形成试验表明,miR-20a抑制剂对miR-20a的下调在体外抑制了MDA-PCa-2b细胞的增殖,并且在体内也抑制了肿瘤的生长。此外,间隙连接蛋白α1(CX43)被鉴定为miR-20a的直接靶基因。在体内和体外用miR-20a抑制剂处理后,在MDA-PCa-2b细胞中检测到CX43的上调。总之,研究结果表明,miR-20a通过靶向CX43显着促进前列腺癌的进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号